C WorldWide Group’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.17M | Hold |
1,260,000
| – | – | 0.03% | 81 |
|
|
2025
Q1 | $4.2M | Hold |
1,260,000
| – | – | 0.05% | 69 |
|
|
2024
Q4 | $9.32M | Hold |
1,260,000
| – | – | 0.11% | 65 |
|
|
2024
Q3 | $11.8M | Hold |
1,260,000
| – | – | 0.12% | 64 |
|
|
2024
Q2 | $10.1M | Buy |
1,260,000
+200,000
| +19% | +$1.6M | 0.11% | 65 |
|
|
2024
Q1 | $15.7M | Sell |
1,060,000
-300,000
| -22% | -$4.45M | 0.18% | 57 |
|
|
2023
Q4 | $11.1M | Hold |
1,360,000
| – | – | 0.15% | 57 |
|
|
2023
Q3 | $6.19M | Hold |
1,360,000
| – | – | 0.08% | 64 |
|
|
2023
Q2 | $9.57M | Hold |
1,360,000
| – | – | 0.12% | 59 |
|
|
2023
Q1 | $8.31M | Hold |
1,360,000
| – | – | 0.11% | 62 |
|
|
2022
Q4 | $8.69M | Buy |
1,360,000
+200,000
| +17% | +$1.28M | 0.12% | 45 |
|
|
2022
Q3 | $11.1M | Hold |
1,160,000
| – | – | 0.15% | 41 |
|
|
2022
Q2 | $12.8M | Buy |
+1,160,000
| New | +$12.8M | 0.16% | 39 |
|
|
2019
Q2 | – | Sell |
-226,681
| Closed | -$2.16M | – | 98 |
|
|
2019
Q1 | $2.16M | Hold |
226,681
| – | – | 0.03% | 93 |
|
|
2018
Q4 | $2.01M | Sell |
226,681
-173,922
| -43% | -$1.54M | 0.03% | 78 |
|
|
2018
Q3 | $4.51M | Buy |
400,603
+15,157
| +4% | +$171K | 0.06% | 70 |
|
|
2018
Q2 | $4.93M | Buy |
+385,446
| New | +$4.93M | 0.07% | 66 |
|